Revenue | ₹2,120.70Cr |
Net Profits | ₹188.96Cr |
Net Profit Margins | 8.91% |
Emcure Pharmaceuticals Ltd’s revenue jumped 18.93% since last year same period to ₹2,120.70Cr in the Q4 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 8.23% jump in its revenue since last 3-months.
Emcure Pharmaceuticals Ltd’s net profit jumped 64.07% since last year same period to ₹188.96Cr in the Q4 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 22.92% jump in its net profits since last 3-months.
Emcure Pharmaceuticals Ltd’s net profit margin jumped 37.95% since last year same period to 8.91% in the Q4 2024-2025. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 13.57% jumped in its net profit margins since last 3-months.
The revenue for Emcure Pharmaceuticals Ltd in the Q4 results 2024 was ₹2,120.70Cr.
The net profit for Emcure Pharmaceuticals Ltd in the Q4 results 2024 was ₹188.96Cr.
The net profit margin for Emcure Pharmaceuticals Ltd in the Q4 results 2024 was 8.91%.
The revenue for Emcure Pharmaceuticals Ltd in the Q4 results 2023 was ₹1,783.10Cr.
The net profit for Emcure Pharmaceuticals Ltd in the Q4 results 2023 was ₹115.17Cr.
The net profit margin for Emcure Pharmaceuticals Ltd in the Q4 results 2023 was 6.46%.